2016 In Review: Message from CEO and Co-Founder Claudia Hesselmann

HOME NEWS 2016 IN REVIEW: MESSAGE FROM CEO AND CO-FOUNDER CLAUDIA HESSELMANN

At ARENSIA, we are looking back on a very good business year, in which we were able to outdo ourselves with regard to outstanding patient enrolment rates in complex Phase 1, 2a, POC studies at our Phase 1 units in Eastern Europe. Studies involved sophisticated logistics, biomarker assessments (e.g. biopsy collection and imaging), intensive PK, hospitalization, in various indications and in populations.

We continue observing high interest from Sponsors in "integrated" protocol designs: First-in-Man in healthy volunteers performed at Phase 1 CROs in Western Europe or US + First-in-Patients performed at ARENSIA´s Phase 1 units in Eastern Europe. This approach has proven to be fast in terms of execution, as well as highly cost efficient.

Immunology, Oncology and Infectious Diseases remained the most striving areas in 2016: ARENSIA units delivered record high recruitment rates in RA, OA, Psoriasis, UC, various cancers, HCV, HBV patients, etc.

ARENSIA initiated a series of self-sponsored workshops dedicated to "Innovative Strategies to achieve first efficacy data / Proof of Concept in record time". Senior executives from pharma and biotech companies are invited to attend in highly interactive format moderated by industry experts. Next two workshops are scheduled for May 24th 2017 in San Francisco and Nov 9th 2017 in Boston. These events shall focus on case studies from Immunology, Oncology and Infectious Diseases. Please kindly get in touch with us if interested.

We take pleasure to update you below on how, in 2016, ARENSIA kept its promise of fast recruitment, quality and innovation, while increasing our capabilities to improve for our Sponsors.

Operational Highlights

Expansion of our client portfolio, with now 13 out of top 20 leading pharma companies worldwide being our Sponsors. In addition, we gained as clients 5 additional biotechs.
Increased collaboration with partner CROs to now 5 global players and 5 mid-size, which sub-contract to ARENSIA the portion of the early phase studies requiring patients. Thus, Sponsors who are bound by global outsourcing agreements can use ARENSIA´s niche expertise and unrivalled speed.
Increase by 25% of the number of on-going projects across all ARENSIA Phase 1 units.
Expansion of our operations to the US through the start-up of clinical operations in Monroe, Louisiana. We are collaborating with a private clinic dedicated to early patient studies. First project, Phase 2a in NASH patients, starts enrolment in early 2017.
Expansion of ARENSIA’s Phase I unit at the "Republican Clinical Hospital" in Chisinau, Moldova to 20 intensive monitoring beds, at state-of-the-art standards.
23 Sponsor audits and 1 HA inspection (Romania) successfully passed.

Organisational and Administrative Highlights

Expansion of Headquarters and relocate into a new location inside the prestigious Düsseldorf Life Sciences Center.
Expansion of our representation in the US by opening a subsidiary in Boston, MA to enable a closer interaction with our North American clients.
Expansion of our central team by two new positions at ARENSIA HQ: full-time Compliance Officer and Director Clinical Operations, both were staffed with exceptionally experienced and capable ARENSIA staff.
Expansion of our Project Management and Admin center for Romania and relocate into downtown Bucharest, enabling shorter commutes to the Phase 1 units in the city.
Expansion of our teams in all locations to support the business growth, and also to fulfil increased administrative requirements from Sponsors and regulatory/legislative bodies.

We stay at your disposal for any questions and feasibilities and look forward to strengthen our collaboration in 2017.

We are grateful for all your support and fruitful interaction.

With kind regards,
Dr. Claudia Hesselmann
CEO and Co-Founder

04.01.2017

This website uses cookies

We use cookies to personalise content and ads, to provide social media features and to analyse our traffic. We also share information about the traffic in our site with our social media, advertising and analytics partners who may combine it with other information that you’ve provided to them or that they’ve collected from your use of their services. Detailed information about the use of necessary cookies, which are essential to browse this website, and optional cookies, which you can select below, and how you can review or withdraw your consent at any time can be found in our Privacy Statement.

Always ON Essentials

Necessary cookies help make a website usable by enabling basic functions like page navigation and access to secure areas of the website. The website cannot function properly without these cookies.

cookiePreference
This essential functionality ensures that your choices regarding data privacy and personalization are respected and consistently applied during your visits. You can seamlessly navigate our website with the confidence that your selected settings are in place, providing a tailored and secure user experience.

Expiry: 1 year Type: Local
cookiePreference-*
This cookie is an advanced component of our website, meticulously designed to track and manage the specific categories of cookies you allow. This innovative functionality ensures that your customized cookie settings are precisely implemented, offering a seamless and personalized browsing experience that aligns with your privacy preferences.

Expiry: 1 year Type: Local

Statistics

Statistic cookies help website owners to understand how visitors interact with websites by collecting and reporting information anonymously.

Google Analytics
We create pseudonymous user profiles with the help of Google Analytics in order to design our websites in line with requirements. Google Analytics uses targeting cookies that are stored on your end device and can be read by us. In this way, we are able to recognize and count returning visitors and find out how often our websites are accessed by different users. Data processing is carried out on the basis of Art. 6 para. 1 lit. a) GDPR (consent) and § 25 para. 1 TDDDG. The information generated by the cookie about your use of our website is usually transmitted to a Google server in the USA and stored there. However, since we have activated IP anonymization on our website, your IP address will be shortened by Google beforehand within member states of the European Union. Only in exceptional cases will the full IP address be transmitted to a Google server in the USA and only shortened there (further information on the purpose and scope of data collection can be found, for example, at https://policies.google.com/privacy?hl=de&gl=de). We have also concluded an order processing contract with Google LLC (USA) in accordance with Art. 28 GDPR. Google will therefore only use all information strictly for the purpose of evaluating the use of our websites for us and compiling reports on website activity.

_ga_
This cookie is used by Google Analytics to persist session state.

Expiry: 1 year 1 month Type: Third-party

_ga
This cookie name is associated with Google Universal Analytics - which is a significant update to Google's more commonly used analytics service. This cookie is used to distinguish unique users by assigning a randomly generated number as a client identifier. It is included in each page request in a site and used to calculate visitor, session and campaign data for the sites analytics reports.

Expiry: 1 year 1 month Type: Third-party
Hotjar
We use Hotjar Observe, a service provided by Hotjar Ltd, 3 Lyons Range, 20 Bisazza Street, Sliema SLM 1640, Malta, on our website. This is a software for the analysis and optimization of online offers on the basis of pseudonymous measurements and analyses of user behavior, which may include in particular A/B tests (measurement of the popularity and user-friendliness of different content and functions), measurement of click paths and interaction with content and functions of the online offer (so-called heat maps and recordings). The legal basis is your consent in accordance with Art. 6 para. 1 lit. a) GDPR and Section 25 para. 1 TDDDG.

_hjSessionUser_*
Set when a user first lands on a page. Ensures data from subsequent visits to the same site are attributed to the same user ID. Persists the Hotjar User ID which is unique to that site. Hotjar does not track users across different sites.

Expiry: 1 year Type: Third-party

_hjSession_*
Holds current session data. Ensures subsequent requests in the session window are attributed to the same session.

Expiry: 1 hour Type: Third-party
Zoom Info
We use the advertising services of ZoomInfo for our website. The service provider is the Canadian company ZoomInfo Technologies LLC, 805 Broadway, Suite 900, Vancouver, WA 98660, Canada. Your data may also be processed in Canada and thus outside the scope of the GDPR. The European Commission has decided that there is an adequate level of protection for commercial offers from Canada in accordance with Art. 45 para. 1 GDPR. This means that data transfer to this country is permitted.

__cf_bm
This cookie is used to distinguish between humans and bots. This is beneficial for the website, in order to make valid reports on the use of their website.

Expiry: 30 minutes Type: Third-party

_zitok
First-party cookie set by ZoomInfo to identify unique visitors.

Expiry: 1 year Type: Third-party

_cfuvid
The _cfuvid cookie is used to allow the Cloudflare WAF to distinguish individual users who share the same IP address. Visitors who do not provide the cookie are likely to be grouped together and may not be able to access the site if there are many other visitors from the same IP address.

Expiry: Session Type: Third-party

Marketing

Marketing cookies are used to track visitors across websites. The intention is to display ads that are relevant and engaging for the individual user and thereby more valuable for publishers and third party advertisers.

Linkedin
Our website uses the “LinkedIn Insight Tag” conversion tool from LinkedIn Ireland Unlimited Company, Wilton Place, Dublin 2, Ireland.This tool creates a cookie in your web browser, which enables the following data to be collected: IP address, device and browser characteristics and page events (e.g. page views). This data is encrypted, anonymized within seven days and the anonymized data is deleted within 90 days. LinkedIn does not share any personal data with us, but offers anonymized reports on the website target group and display performance. LinkedIn also offers the option of retargeting via the Insight Tag.

AnalyticsSyncHistory
Used to store information about the time a sync with the lms_analytics cookie took place for users in the Designated Countries.

Expiry: 1 month Type: Third-party

li_gc
Used to store guest consent to the use of cookies for non-essential purposes

Expiry: 6 months Type: Third-party

lidc
Facilitates data center selection.

Expiry: 1 day Type: Third-party

UserMatchHistory
This cookie is used to track visitors so that more relevant ads can be presented based on the visitor's preferences.

Expiry: 1 month Type: Third-party

bscookie
Used for remembering that a logged in user is verified by two factor authentication and has previously logged in.

Expiry: 1 year Type: Third-party

bcookie
Browser Identifier cookie to uniquely identify devices accessing LinkedIn to detect abuse on the platform .

Expiry: 1 year Type: Third-party

li_sugr
Used to make a probabilistic match of a user's identity.

Expiry: 3 months Type: Third-party

Allow all Allow selection Deny

2016 In Review: Message from CEO and Co-Founder Claudia Hesselmann

GET IN TOUCH

USEFUL INFORMATION